Survey of Awareness and Perceptions of Canadians on the Benefits and Risks of Clinical Trials

被引:8
|
作者
Willison, Donald J. [1 ]
Richards, Dawn P. [2 ]
Orth, Alison [3 ]
Harris, Heather [4 ]
Marlin, Susan [2 ]
机构
[1] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON M5T 3M6, Canada
[2] Clin Trials Ontario, Toronto, ON, Canada
[3] Clin Trials BC, Vancouver, BC, Canada
[4] Can SOLVE CKD Network, Vancouver, BC, Canada
关键词
public opinion; clinical trials; Canada; PUBLIC AWARENESS; PARTICIPATION; BARRIERS; CANCER;
D O I
10.1177/2168479018805433
中图分类号
R-058 [];
学科分类号
摘要
Background: Little is known about the Canadian public's perspective regarding clinical trials. Methods: We surveyed 1602 Ontario and British Columbia residents to ascertain their understanding of and willingness to participate in clinical trials. Results: Clinical trials are regarded positively with overall perceptions that they provide societal and personal benefits. Most respondents were somewhat (49%) or very willing (19%) to participate in a clinical trial. This increased with age and level of education. It was also greater among those with poor or very poor health, those with multiple chronic conditions, and those who had previously been invited into a clinical trial, all of which were correlated with age. Still, there was room for improvement in awareness and understanding of clinical trials. Forty-three percent of those surveyed felt not very informed or not at all informed and 37% had no opinion regarding clinical trials. Respondents would most often turn to their treating physician if considering participating in a clinical trial and least often to social media. Conclusion: While Canadians' views about clinical trials are generally positive, they are somewhat muted and a significant minority feels poorly or not at all informed. They are less willing to participate in clinical research than Americans and are roughly equivalent to Europeans. While clinicians are the top choice for learning about clinical trials, they have little or no training and little time for this role. As we move toward integrating clinical trials into the practice setting, these issues of time, training, and resources must be addressed.
引用
收藏
页码:669 / 677
页数:9
相关论文
共 50 条
  • [1] Survey of Gene Therapy Researchers' Perceptions and Assessment of Risks in Clinical Trials
    Deakin, Claire T.
    Alexander, Ian E.
    Kerridge, Ian
    [J]. MOLECULAR THERAPY, 2012, 20 : S78 - S78
  • [2] Cancer clinical trials: Risks and benefits
    Murphy, SB
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2001, 23 (09) : 564 - 567
  • [3] Defining benefits and risks for SERMs in clinical trials and clinical practice
    Johnson, SR
    Dunn, BK
    Anthony, M
    [J]. SELECTIVE ESTROGEN RECEPTOR MODULATORS (SERMS), 2001, 949 : 304 - 314
  • [4] Decision theory and the evaluation of risks and benefits of clinical trials
    Bernabe, Rosemarie D. C.
    van Thiel, Ghislaine J. M. W.
    Raaijmakers, Jan A. M.
    van Delden, Johannes J. M.
    [J]. DRUG DISCOVERY TODAY, 2012, 17 (23-24) : 1263 - 1269
  • [5] Commercializing clinical trials - Risks and benefits of the CRO boom
    Shuchman, Miriam
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (14): : 1365 - 1368
  • [6] Weighing the benefits and risks in clinical trials and practice - Introduction
    McCaskill-Stevens, W
    [J]. SELECTIVE ESTROGEN RECEPTOR MODULATORS (SERMS), 2001, 949 : 279 - 279
  • [7] Awareness and perceptions of clinical trials in patients with cancer and their families in Turkey
    Kubilay, Pinar
    Erol, Cihan
    Kahraman, Seda
    Tacar, Seher Yildiz
    Ozcan, Erkan
    Basal, Fatma Bugdayci
    Kose, Fatih
    Sendur, Mehmet Ali Nahit
    Tural, Deniz
    Cicin, Irfan
    Oksuzoglu, Berna
    Urun, Yuksel
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [8] Risks and benefits of hormone replacement therapy - Clinical trials report
    Kotchen, TA
    Mansour, G
    Mansour, J
    [J]. CURRENT HYPERTENSION REPORTS, 2003, 5 (06) : 483 - 485
  • [9] Assessing and communicating the risks and benefits of gene transfer clinical trials
    Kim, Scott Y. H.
    [J]. CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2006, 8 (05) : 384 - 389
  • [10] Standardization of retinopathy of prematurity clinical examinations in clinical trials: risks, benefits and alternatives
    Good, William V.
    [J]. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2008, 36 (01): : 1 - 2